Editorial: Next generation B cell targeting therapies in autoimmune diseases

• Rui Li,
• Rui Li,
• Rui Li,
• Jiahui Zhu,
• Shenyue Wang,
• Bo Zhang,
• Linlu Tian,
• Ying Fu,
• Ying Fu

Affiliations

Rui Li

Institute of Immunotherapy, Fujian Medical University, Fuzhou, Fujian, China

Rui Li

Department of Neurology and Institute of Neurology of First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China

Rui Li

Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States

Jiahui Zhu

Department of Neurology and Institute of Neurology of First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China

Shenyue Wang

Department of Neurology and Institute of Neurology of First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China

Bo Zhang

Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, Fujian, China

Linlu Tian

Department of Immunology, Harbin Medical University, Harbin, Heilongjiang, China

Ying Fu

Department of Neurology and Institute of Neurology of First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China

Ying Fu

Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, Fujian, China